Nidan Labs & Healthcare Complete Financial Statements
In FYNone, Nidan Labs & Healthcare (NIDAN) reported revenue ₹24 Cr, net profit ₹3 Cr and EPS ₹2.90, with a net profit margin of 7.4% and ROE of 2.9%. Full financial statements from FY2019 to FY2025 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Nidan Labs & Healthcare share price today.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NIDAN Revenue, Net Profit & EBITDA — Year-on-Year Growth
NIDAN YoY (March 2025 vs Period) — revenue -11.1%, net profit +50.0%, EBITDA +28.6%, expenses -25.0%.
NIDAN Income Statement — Revenue, EBITDA & Net Profit
Nidan Labs & Healthcare revenue ₹24 Cr, EBITDA ₹9 Cr, net profit ₹3 Cr, EPS ₹2.90 (None) — net profit margin 7.4%. Explore Nidan Labs & Healthcare intrinsic price to estimate fundamental worth using multiple valuation models.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 27 | 27 | 28 | 30 | 21 | 22 | 21 |
| Expenses | 15 | 20 | 18 | 18 | 20 | 12 | 15 | 13 |
| EBITDA | 9 | 7 | 9 | 10 | 10 | 10 | 8 | 8 |
| Operating Profit Margin % | 19.00% | 21.00% | 27.00% | 28.00% | 32.00% | 44.00% | 34.00% | 38.00% |
| Depreciation | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 3 | 2 | 2 | 2 | 3 | 4 | 4 | 5 |
| Profit Before Tax | 4 | 3 | -2 | 5 | 5 | 3 | 1 | 0 |
| Tax | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 |
| Net Profit | 3 | 2 | -3 | 4 | 3 | 2 | 1 | 0 |
| Earnings Per Share (₹) | 2.90 | 1.42 | -2.33 | 2.55 | 2.32 | 2.33 | 0.72 | 0.23 |
NIDAN Balance Sheet — Assets, Liabilities & Shareholders' Equity
NIDAN total assets ₹83 Cr, total equity ₹68 Cr, total liabilities ₹ Cr (2025) — ROE 2.9%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 83 | 83 | 84 | 89 | 54 | 45 | 43 |
| Current Assets | 11 | 30 | 21 | 25 | 23 | 24 | 19 |
| Fixed Assets | 16 | 18 | 21 | 21 | 20 | 20 | 23 |
| Capital Work in Progress | 0 | 0 | 0 | 4 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 67 | 65 | 63 | 64 | 34 | 25 | 20 |
| LIABILITIES | |||||||
| Total Liabilities | |||||||
| Current Liabilities | 5 | 5 | 5 | 10 | 14 | 34 | 32 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 68 | 66 | 69 | 66 | 13 | 11 | 10 |
| Share Capital | 14 | 14 | 14 | 14 | 10 | 10 | 10 |
| Reserves & Surplus | 54 | 52 | 56 | 52 | 3 | 1 | 0 |
NIDAN Cash Flow Statement — Operating, Investing & Financing
Nidan Labs & Healthcare operating cash flow ₹2 Cr, investing ₹0 Cr, financing ₹-3 Cr, net cash flow ₹-1 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | 2 | 6 | 11 | 8 | 4 | 5 | 9 |
| Investing Activities | 0 | -11 | 0 | -36 | -3 | 0 | 1 |
| Financing Activities | -3 | -1 | -10 | 29 | -1 | -2 | -6 |
| Net Cash Flow | -1 | -6 | 0 | 1 | 0 | 3 | 4 |